Human metapneumovirus infection in children with a history of prematurity

CHUN-YI LULI-MIN HUANG2021-01-082021-01-0820161875-9572https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957438825&doi=10.1016%2fj.pedneo.2015.12.003&partnerID=40&md5=2f9949f7e70242f857c093b3a1bc4459https://scholars.lib.ntu.edu.tw/handle/123456789/539905[SDGs]SDG3[SDGs]SDG5Human metapneumovirus vaccine; monoclonal antibody; palivizumab; unclassified drug; virus vaccine; child; disease severity; drug efficacy; Editorial; fetus lung maturity; human; Human metapneumovirus; Human metapneumovirus infection; immunization; infection prevention; newborn care; nonhuman; pneumonia; prematurity; seroprevalence; survival rate; viral respiratory tract infection; virus load; attention; hospitalization; infant; Metapneumovirus; prematurity; Attention; Child; Hospitalization; Humans; Infant; Infant, Premature; MetapneumovirusHuman metapneumovirus infection in children with a history of prematurity - A condition worth more attentioneditorial10.1016/j.pedneo.2015.12.003268035812-s2.0-84957438825